drugset / Trial / NCT02603744

Autologous Adipose Derived Mesenchymal Stromal Cells Transplantation in Women With Premature Ovarian Failure (POF)

NCT02603744 ↗

Phase 1/2 Unknown 9 enrolled Royan Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this study is to determine safety and tolerability and of intra-ovarian injection of adipose derived stromal cell in women with premature ovarian failure and to study the preliminary efficacy ADSCs intra ovarian injection on ovarian function improvement.

Timeline

Start
2015-06
Primary completion
2018-06
Completion
2018-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Adipose derived Stromal cells (ADSCs) Cell therapy 5e+06 cells Other
Subject Adipose derived Stromal cells (ADSCs) Cell therapy 1e+07 cells Other
Subject Adipose derived Stromal cells (ADSCs) Cell therapy 1.5e+07 cells Other